The Miami longevity startup says it hopes to rea
Author: Michael
AbbVie’s JUVMO (tavapadon) targets dopamine di
Six of ten patients in a small trial improved by
Alector has granted Genentech exclusive worldwide
Coya Therapeutics has completed enrollment of the
Alterity presented additional analyses of its ATH
Genflow Biosciences presented interim results fro
Deerfield’s Jim Flynn on shrinking error bars,
Annovis Bio is using an AI tool to speed up its
Aged beagle data hint at lower biological age an